Adenosine recalls

The FDA has published 3 recalls involving Adenosine since 2018. The latest was reported on 25 Aug 2021. Most were for sterility. Teva Pharmaceuticals U has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 25 Aug 2021

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why adenosine is recalled

Sterility3100%

Companies

Teva Pharmaceuticals U267%
Pharmedium Services133%

By year

2021267%
2018133%

All adenosine recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
25 Aug 2021Drug	CLASS II	Adenosine Injection, USP, 60mg/ (3 mg/mL) single-dose vial recalled	Teva Pharmaceuticals U	Sterility	Nationwide
25 Aug 2021Drug	CLASS II	Adenosine Injection, USP, 60mg/ (3 mg/mL) single-dose vial recalled	Teva Pharmaceuticals U	Sterility	Nationwide
28 Feb 2018Drug	CLASS II	Adenosine Injection in all strengths, all doses, and all packaging recalled	Pharmedium Services	Sterility	Nationwide

Should you stop taking Adenosine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.